426 related articles for article (PubMed ID: 19246010)
21. Structure of human methionine aminopeptidase-2 complexed with fumagillin.
Liu S; Widom J; Kemp CW; Crews CM; Clardy J
Science; 1998 Nov; 282(5392):1324-7. PubMed ID: 9812898
[TBL] [Abstract][Full Text] [Related]
22. Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity.
Morgen M; Jöst C; Malz M; Janowski R; Niessing D; Klein CD; Gunkel N; Miller AK
ACS Chem Biol; 2016 Apr; 11(4):1001-11. PubMed ID: 26686773
[TBL] [Abstract][Full Text] [Related]
23. Methionine aminopeptidase 2 is required for HSC initiation and proliferation.
Ma AC; Fung TK; Lin RH; Chung MI; Yang D; Ekker SC; Leung AY
Blood; 2011 Nov; 118(20):5448-57. PubMed ID: 21937698
[TBL] [Abstract][Full Text] [Related]
24. Fumagillin inhibits colorectal cancer growth and metastasis in mice: in vivo and in vitro study of anti-angiogenesis.
Hou L; Mori D; Takase Y; Meihua P; Kai K; Tokunaga O
Pathol Int; 2009 Jul; 59(7):448-61. PubMed ID: 19563408
[TBL] [Abstract][Full Text] [Related]
25. Treatment of cells with the angiogenic inhibitor fumagillin results in increased stability of eukaryotic initiation factor 2-associated glycoprotein, p67, and reduced phosphorylation of extracellular signal-regulated kinases.
Datta B; Majumdar A; Datta R; Balusu R
Biochemistry; 2004 Nov; 43(46):14821-31. PubMed ID: 15544353
[TBL] [Abstract][Full Text] [Related]
26. FGFR1/PI3K/AKT signaling pathway is a novel target for antiangiogenic effects of the cancer drug fumagillin (TNP-470).
Chen GJ; Weylie B; Hu C; Zhu J; Forough R
J Cell Biochem; 2007 Aug; 101(6):1492-504. PubMed ID: 17295210
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and evaluation of a cellular stable and detectable biotinylated fumagillin probe and investigation of cell permeability of fumagillin and its analogs to endothelial and cancer cells.
Zhou GC; Liu F; Wan J; Wang J; Wang D; Wei P; Ouyang P
Eur J Med Chem; 2013; 70():631-9. PubMed ID: 24211639
[TBL] [Abstract][Full Text] [Related]
28. A chemical and genetic approach to the mode of action of fumagillin.
Zhang Y; Yeh JR; Mara A; Ju R; Hines JF; Cirone P; Griesbach HL; Schneider I; Slusarski DC; Holley SA; Crews CM
Chem Biol; 2006 Sep; 13(9):1001-9. PubMed ID: 16984890
[TBL] [Abstract][Full Text] [Related]
29. Nosema ceranae escapes fumagillin control in honey bees.
Huang WF; Solter LF; Yau PM; Imai BS
PLoS Pathog; 2013 Mar; 9(3):e1003185. PubMed ID: 23505365
[TBL] [Abstract][Full Text] [Related]
30. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.
Skinner-Adams TS; Lowther J; Teuscher F; Stack CM; Grembecka J; Mucha A; Kafarski P; Trenholme KR; Dalton JP; Gardiner DL
J Med Chem; 2007 Nov; 50(24):6024-31. PubMed ID: 17960925
[TBL] [Abstract][Full Text] [Related]
31. Plasmodium falciparum calcineurin and its association with heat shock protein 90: mechanisms for the antimalarial activity of cyclosporin A and synergism with geldanamycin.
Kumar R; Musiyenko A; Barik S
Mol Biochem Parasitol; 2005 May; 141(1):29-37. PubMed ID: 15811524
[TBL] [Abstract][Full Text] [Related]
32. Phylogenetic relationships of methionine aminopeptidase 2 among Encephalitozoon species and genotypes of microsporidia.
Pandrea I; Mittleider D; Brindley PJ; Didier ES; Robertson DL
Mol Biochem Parasitol; 2005 Apr; 140(2):141-52. PubMed ID: 15760654
[TBL] [Abstract][Full Text] [Related]
33. Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese.
Wang J; Sheppard GS; Lou P; Kawai M; Park C; Egan DA; Schneider A; Bouska J; Lesniewski R; Henkin J
Biochemistry; 2003 May; 42(17):5035-42. PubMed ID: 12718546
[TBL] [Abstract][Full Text] [Related]
34. A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization.
Krungkrai SR; DelFraino BJ; Smiley JA; Prapunwattana P; Mitamura T; Horii T; Krungkrai J
Biochemistry; 2005 Feb; 44(5):1643-52. PubMed ID: 15683248
[TBL] [Abstract][Full Text] [Related]
35. M17 leucine aminopeptidase of the human malaria parasite Plasmodium vivax.
Lee JY; Song SM; Seok JW; Jha BK; Han ET; Song HO; Yu HS; Hong Y; Kong HH; Chung DI
Mol Biochem Parasitol; 2010 Mar; 170(1):45-8. PubMed ID: 19931315
[TBL] [Abstract][Full Text] [Related]
36. Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei.
Kumaratilake LM; Robinson BS; Ferrante A; Poulos A
J Clin Invest; 1992 Mar; 89(3):961-7. PubMed ID: 1541684
[TBL] [Abstract][Full Text] [Related]
37. Understanding the selectivity of fumagillin for the methionine aminopeptidase type II.
Klein CD; Folkers G
Oncol Res; 2003; 13(12):513-20. PubMed ID: 12899241
[TBL] [Abstract][Full Text] [Related]
38. Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials.
Skinner-Adams TS; Stack CM; Trenholme KR; Brown CL; Grembecka J; Lowther J; Mucha A; Drag M; Kafarski P; McGowan S; Whisstock JC; Gardiner DL; Dalton JP
Trends Biochem Sci; 2010 Jan; 35(1):53-61. PubMed ID: 19796954
[TBL] [Abstract][Full Text] [Related]
39. Human malaria parasite orotate phosphoribosyltransferase: functional expression, characterization of kinetic reaction mechanism and inhibition profile.
Krungkrai SR; Aoki S; Palacpac NM; Sato D; Mitamura T; Krungkrai J; Horii T
Mol Biochem Parasitol; 2004 Apr; 134(2):245-55. PubMed ID: 15003844
[TBL] [Abstract][Full Text] [Related]
40. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
